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INTRODUCTION:  
Obesity is frequently acquainting as an abnormal accumulation of body fat to the degree that may cause serious 
health consequences. ( Yanovski et al., 2014). One of the most common complication of obesity is obstructive 
sleep apnea(OSA). Obstructive Sleep Apnea is a widespread complaint that is closely associated with global 
obesity epidemics, and it is described as frequent complete or partial flop of the upper airway during sleep 
leading to gaseous exchange impairment and disturbance of sleep. It is the commonest category of sleep 
disordered breathing (SDB) in the world as reported in different epidemiological studies. (McNicholas et al., 
2007).   
Central sleep apnea : is described  as decreased respiratory effort leading to decrease or absence of 
ventilation .While in mixed apnea it is categorized by starting centrally and ending with obstructive events.In 
obstructive sleep apnea: the effort of  respiration is preserved but ventilation decrement  or absence due to partial 
or total obstruction in the upper airway; apnea is well-defined as the total airflow cessation lasting 10 sec. or 
more , There are three types of apneas :obstructive, central and mixed . A hypopnea: is defined as a reduction in 
airflow (30-50%) that is followed by an arousal from sleep or a decrease in oxyhaemoglobin saturation (3-
4%)( The Report of an American Academy of Sleep Medicine Task Force, 1999 and Kushida et al.,2005). 
The severity of sleep apnea is evaluated with apnea-hypopnea index (AHI), which is the number of 
apneas and hypopneas per hour of sleep. 
According to the American Academy of sleep Medicine recommendations , OSA is defined with 
AHI>5., and it is classified as mild OSA with AHI of 5 to 15;moderate OSA with AHI of 16 to 30;and severe 
OSA with AHI > 30.(The Report of an American Academy of Sleep Medicine Task Force, 1999). 
The Apnea–Hypopnea Index or Apnoea–Hypopnoea Index (AHI) is an index used to determine sleep 
apnea severity. It is characterized by the number of apnea and hypopnea events per hour of sleep. The apneas 
(pauses in breathing) must last for at least 10 seconds and associated with a decrease in blood oxygenation. 
Combining AHI and oxygen desaturation measurement gives a complete sleep apnea severity score that assesses 
the number of sleep disruptions and degree of oxygen desaturation.  (Ruehland et al.,2009 ). 
The AHI is calculated by dividing the number of apnea events by the number of hours of sleep. AHI 
values are categorized as 
Normal: 0-4;Mild Sleep Apnea: 5-14;Moderate Sleep Apnea: 15-29; Severe Sleep Apnea: 30 or 
more.(Ruehland et al., 2009 ). 
Prevalence of Obstructed Sleep Apnea: 
Worldwide , it is about 2-5 per cent for adult females and 3-7 per cent for adult males in the general population. 
(Punjabi, 2008). Therefore, OSA it's prevalence in men much more than in women, approximately 2 to 3 times 
that of women. In addition, OSA prevalence is the same in Caucasians and Asians, and it is noticed that OSA is 
not only common in developed but also in developing countries. Nevertheless, the prevalence of OSA is greater 
in overweight or obese elderly people and those of different ethnic origins . And  these results were explained 
mainly by the increased obesity indices (Villaneuva  et al., 2005). 
Diagnosis of Obstructive sleep apnea:  
The novel test for  diagnosis  of OSA is the in-laboratory overnight polysomnography. (The Report of an 
American Academy of Sleep Medicine Task Force., 1999 and Kushida  et al., 2005).Another option for 
diagnosis of OSA is polysomnography at Home (unattended )is a feasible choice for detecting patients with 
moderate to high clinical suspicion for sleep-disordered breathing ,However ,subjects with un successful or non-
conclusive studies or with negative studies but still suffering from symptoms should go through standardized 
polysomnography  .(Boyer and Kapur, 2003 and Collop , 2008). 
Since the access to polysomnography is not possible we use Berline Questionnaire to assess the patients 
with OSA. 
Nerve conduction studies :Nerve conduction studies are the most informative portion of the 
electrodiagnostic evaluation for a peripheral neuropathy. It is preferable to design a nerve conduction study for 
each patient to answer specific questions. The plan of the examination is as important as interpretation of the 
results (Shin, 2001). 
Nerve conduction studies is used in diagnosis of neuropathy at sensitivity of about 90% in utmost ;if the 
right test is  chosen ; focal and diffuse neuropathies (Shin, 2001and Yasuda et al.,2007). 
The NCS can precisely  measures the peripheral nerves ability to transmit electrical signals and shows  
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atypical results if pathology are exist in the nerve. Studying  both sensory and motor fibers function of upper and 
lower limbs ideally illustrate the presence, severity and distribution, of peripheral nerve disease (Albers et al., 
1995 and Costa et al., 2006).  As extension of the clinical neurological examination the NCS is  used to examine 
peripheral nerve functions  as it is accurate, most reliable, , informative and sensitive measure. Moreover, these 
tests had always been considered as the gold standard for diagnosis of all neuropathies (Kimura, 2013).The NCS 
results relate with clinical endpoints, and the amplitudes  of the nerve reveal the degree of nerve fiber loss which 
characterizes the pathological hallmark of Diabetic Peripheral Neuropathy. Standardized methods improve the 
reliability of testing such that NCS have the lowest degree of variance of all tests for Diabetic Peripheral 
Neuropathy (Perkins and Brill, 2003). The accuracy of NCS in  diagnosis can be increased by examining other 
parameters such as F-wave testing, ratio of sural-to-radial sensory nerve potential amplitudes, conduction studies 
for the planter sensory nerve, and combination of anthropomorphic factors such as height and weight (Kikawa et 
al., 2005 and Uluc et al., 2008). 
1  -Motor nerve conduction study (MNCS): 
Different aspects of peripheral motor nerves that innervate a somatic muscle can be evaluated by MNCS. 
Compound muscle action potential (CMAP), is the electrical response obtained by stimulation of motor nerve is 
called which represents summated electrical activity of the muscle fibers that are in the region of recording 
electrode and that are innervated by that particular nerve (Aminoff, 2012). 
The latency or distal motor latency (DML) of the motor response is the time in millisecond from the 
giving the stimulus to the early deflection from the baseline, could be  positive or negative. It represents the time 
required for the action potential in the fastest conducting fibers to reach the nerve terminals and activate the 
muscle fibers. The amplitude is the elevation in millivolt from the baseline to the peak of the negative phase and 
it signifies the number of muscle fibers activated and offers an estimation of the sum of functioning nerve and 
muscle fibers. The conduction velocity (CV) is the speed of conduction in nerve fibers that is measured in 
meter/second . (Uluc et al.,2008). 
2-Sensory nerve conduction study (SNCS): 
The sensory nerve action potential (SNAP) signifies the summation of the single nerve fiber action potentials 
that is  recorded from a sensory nerve and reveals the dorsal root ganglion cells integrity with their peripheral 
axons (Kimura, 2013).The latency, amplitude and conduction velocity are measured for sensory nerve fibers as 
are for motor nerve fibers and usually reflect same principles (Aminoff, 2012). 
 
MATERIALS AND METHODS: 
One hundred fifty female were included in this study (75female were classified as overweight or obese) & (75 
female with normal BMI).Their age range from 18-60 Years. 
All participants subjected to the same clinical, biochemical and neurophysiological tests. 
1- Sensory Nerve Conduction Studies 
The stimulus intensity was 20-30% above the current necessary to arouse a maximal sensory nerve action 
potential. The supra maximal stimulating current was kept below threshold for motor fibers especially in the 
mixed nerves, since sensory fibers generally, had lower threshold of stimulation than that of motor fibers 
(Aminoff, 2012). 
The sites of the electrodes for sensory nerve conduction studies for the tested nerves were as the follow: 
Median Nerve  
Stimulation: Stimulation was applied with electrode at the plantar aspect of forearm near the wrist joint between 
the tendons of palmaris longus and flexor carpi radials 
Recording: the recording electrode was placed over the median nerve at the index finger (Imada et al., 2007). 
Ulnar Nerve 
Stimulation: stimulation was applied with surface electrodes at the wrist, just radial to the flexor carpi ulnaris. 
Recording: the recording electrode was placed over the ulnar nerve around the fifth digit (Aminoff, 2012). 
Sural Nerve   
Stimulation: stimulation electrodes was placed lateral to the mid-line of the calf 12cm proximal to the recording 
electrode. 
Recording: the recording needle was inserted posterior and below the lateral malleolus of the fibula 
(uluc et al., 2008). 
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RESULT 
Peripheral Neuropathy in Study Groups among Sensory Nerves 
Variable 
Study groups 
Total  X2 
Odds Ratio 
(95% C.I.) P value Case 
 (%) 
Control  
 (%) 
LT Median Sensory  
Normal  
Abnormal  
 
 
 
64(85.3)  
11(14.7)  
 
 
75 (100.0) 
0 (0.0) 
 
 
139 (92.7%) 
11 (7.3%) 
 
11.871 
 
2.17 (1.81-2.60) 
 
<0.001* 
LT Ulnar sensory  
Normal  
Abnormal 
 
 
69(92.0)  
6 (8.0) 
 
 
73(97.3) 2 
(2.7) 
 
 
142(94.7%) 
8 (5.3%) 
 
2.113 
 
3.17 (1.62-16.26) 
 
0.146 
RT Median Sensory 
Normal  
Abnormal 
 
 
62(82.7)  
13(17.3)  
 
 
69(92.0)  
6 (8.0) 
 
 
131(87.3%)  
19 (12.7%) 
 
2.953 
 
2.41 (0.86-6.73) 
 
0.086 
RT Ulnar sensory  
Normal  
Abnormal 
 
 
72(96.0) 3 
(4.0) 
 
75 (100.0) 
0 (0.0) 
 
147 (98.0%) 
3 (2.0%) 
 
3.061 
 
0.49 (0.41-0.58) 
 
0.080 
LT Sural sensory  
Normal  
Abnormal 
 
 
64(85.3)  
11(14.7)  
 
75 (100.0) 
0 (0.0) 
 
139  
(92.7%) 
11 (7.3%) 
11.871 2.17 (1.81-2.60) 0.001* 
RT Sural sensory  
Normal  
Abnormal 
 
 
57(76.0)  
18(24.0)  
 
72 (96.0) 
3 (4.0) 
 
129 (86.0%) 
21 (14.0%) 
12.458 7.57 (2.13-27.01) 0.001* 
 
Association of Obstructive Sleep Apnea risk with Nerve Conduction Study Findings 
 
Variable Obstructive Sleep Apnea X2 P value 
High (%) Low (%) 
LT. Median  Sensory 
Normal  
Abnormal 
 
29 (82.9) 
6 (17.1) 
 
35 (87.5) 
5 (12.5) 
 
0.322 
 
0.571 
LT Ulnar sensory  
Normal  
Abnormal 
 
31 (88.6) 
4 (11.4) 
 
38 (95.0) 
2 (5.0) 
 
1.048 
 
0.409a 
RT Median Sensory 
Normal  
Abnormal 
 
26 (74.3) 
9 (25.7) 
 
36 (90.0) 
4 (10.0) 
 
3.217 
 
0.073 
RT Ulnar sensory  
Normal  
Abnormal 
 
33 (94.3) 
2 (5.7) 
 
39 (97.5) 
1 (2.5) 
 
0.502 
 
0.596a 
LT Sural sensory  
Normal  
Abnormal 
 
30 (85.7) 
5 (14.3) 
 
34 (85.0) 
6 (15.0) 
 
0.008 
 
0.930a 
RT Sural sensory  
Normal  
Abnormal 
 
25 (71.4) 
10 (28.6) 
 
32 (80.0) 
8 (20.0) 
 
0.752 
 
0.386a 
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Mean Difference of Apnea Hypopnea Index by Nerve Conduction Study Findings 
Variable 
AHI 
Mean ± SD 
t-test P value 
LT Median Sensory 
Normal (64) 
Abnormal (11) 
 
8.22±5.64 
9.36±6.41 
 
0.610 
 
0.544 
LT Ulnar sensory 
Normal (69) 
Abnormal (6) 
 
7.93±5.16 
13.67±9.35 
 
2.431 
 
0.018* 
RT Median Sensory 
Normal (62) 
Abnormal (13) 
 
8.08±5.83 
9.85±5.16 
 
1.011 
 
0.316 
RT Ulnar sensory 
Normal (72) 
Abnormal (3) 
 
8.07±5.25 
16.00±12.00 
 
2.426 
 
0.018* 
LT Sural sensory 
Normal (64) 
Abnormal (11) 
 
8.28±5.93 
9.00±4.58 
 
0.382 
 
0.703 
RT Sural sensory 
Normal (57) 
Abnormal (18) 
 
8.02±5.87 
9.55±5.24 
 
0.993 
 
0.324 
 
Association of Apnea Hypopnea Index Categories with Nerve Conduction Study Findings 
Variable 
AHI Categories 
X
2 P value 
Normal (%) Mild (%) Moderate (%) 
LT Median Sensory 
Normal 
Abnormal  
 
27 (84.4) 
5 (15.6) 
 
31 (91.2) 
3 (8.8) 
 
6 (66.7) 
3 (33.3) 
 
3.367a 
 
0.183 
LT Ulnar sensory 
Normal 
Abnormal 
 
30 (93.8) 
2 (6.3) 
 
33 (97.1) 
1 (2.9) 
 
6 (66.7) 
3 (33.3) 
 
6.584a 
 
0.031* 
RT Median Sensory 
Normal 
Abnormal 
 
28 (87.5) 
4 (12.5) 
 
27 (79.4) 
7 (20.6) 
 
7 (77.8) 
2 (22.2) 
 
0.923 
 
0.630 
RT Ulnar sensory 
Normal 
Abnormal 
 
31 (96.9) 
1 (3.1) 
 
34 (100.0) 
0 (0.0) 
 
7 (77.8) 
2 (22.2) 
 
6.114a 
 
0.018* 
LT Sural sensory 
Normal 
Abnormal 
 
28 (87.5) 
4 (12.5) 
 
28 (82.4) 
6 (17.6) 
 
8 (88.9) 
1 (11.1) 
 
0.450 
 
0.897 
 
RTSural sensory 
Normal 
Abnormal 
 
 
25 (78.1) 
7 (21.9) 
 
 
26(76.5)  
8 (23.5) 
 
 
6 (66.7) 
3 (33.3) 
 
 
0.513 
 
 
0.774 
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Correlation of Apnea Hypopnea Index with Sensory and Motors Nerves’ Latency, Amplitude and  
Conduction Velocity  
Nerves 
Nerve (Mean± 
SD) 
AHI (Mean± SD) r P value 
LT Median Sensory 
Latency (ms) 
Amplitude (µV) 
2.44±0.48 
36.47±19.26 
8.38±5.73 
8.38±5.73 
 
0.091 
-0.393 
0.250 
0.001* 
LT Ulnar sensory 
Latency (ms) 
Amplitude (µV) 
 
2.05± 0.22 
38.03± 18.69 
8.38±5.73 
8.38±5.73 
 
 
0.028 
-0.304 
 
0.735 
0.001* 
RT Median Sensory 
Latency (ms) 
Amplitude (µV) 
 
2.42± 0.52 
33.21± 19.08 
8.38±5.73 
8.38±5.73 
 
 
0.042 
-0.279 
 
0.609 
0.001* 
RT Ulnar sensory 
Latency (ms) 
Amplitude (µV) 
 
2.07± 0.27 
36.44± 18.71 
8.38±5.73 
8.38±5.73 
 
 
-0.079 
-0.300 
 
0.339 
0.001* 
LT. Sural sensory 
Latency (ms) 
Amplitude (µV) 
 
2.27±0.39 
17.70±9.90 
 
 
8.38±5.73 
8.38±5.73 
 
 
0.003 
-0.294 
 
0.974 
0.001* 
RT. Sural sensory 
Latency (ms) 
Amplitude (µV) 
 
2.29±0.39 
16.19±7.43 
 
 
8.38±5.73 
8.38±5.73 
 
 
0.028 
-0.331 
 
0.735 
0.001* 
     
 
DISCUSSION 
It is well known that one of the complication of obesity is sleep apnea . And sleep apnea which disturb the sleep 
leading to obesity ,therefore sleep apnea can affect nerve function by different mechanisms . Severity of sleep 
apnea is evaluated by apnea –hypopnea index(AHI).As AHI is increased that mean more frequent the patient 
stop breathing and more hypoxia and this hypoxia leads to more deterioration of nerve function. 
Low and his co-workers, (1986)and  Ludemann and his co-workers ,(2001)  showed that chronic 
hypoxaemia decelerate the nerve conduction velocity and  Studies of the oxygen consumption in the 
microenvironment of the peripheral nerve under conditions of nerve oedema and experimental diabetic 
neuropathy show that the peripheral nerve function is oxygen dependent. Axonal transport is an energy requiring 
process and its impairment by hypoxaemia can enhance axonal degeneration. 
There are many explanations by which hypoxia can disturb nerve function: 
(Mayer et al.,1999) demonstrated that Hypoxic neuropathies causing hyperplasia and hypertrophy of 
the capillary endothelial cell  of the nerve ,and this hypertrophy and hyperplasia, prompting luminal occlusion 
this may inhibit the transport of oxygen and nutrients. This explanation appear to be valid to peripheral nerve 
dysfunction and lesions, resulting from impaired axonal transport and causing axonal degeneration .And this is 
consistent with the finding demonstrated in table (4.10) that reveal strong negative correlation between the AHI 
and the amplitude of some nerves that indicate axonal injury and degeneration. 
Meanwhile Lim and his co-workers, ( 2010) had revealed that the patterns of  sleep apnea oxygenation 
have been influential in explaining the injury mechanisms. The hypoxia/re-oxygenation events result in 
inflammatory, oxidative, and endoplasmic reticulum stress responses in susceptible groups of nerves. 
For the time being Paiva and Attarian said that OSA creates a proinflammatory state with high levels of 
TNF-α and other cytokines. If left untreated, OSA can cause significant neurological problems including 
peripheral neuropathy ,stroke, headaches, cognitive decline, depression, and non-arteritic ischemic optic 
neuropathy as these literature stated by the scientist Paiva and Attarian ,(2014). 
The cardinal feature that is associated with sleep apnea is intermittent hypoxia  and it will lead to 
endothelial dysfunction, systemic inflammation , oxidative stress, metabolic abnormalities Relationships 
between Intermittent Hypoxia  and nerve conductance abnormalities have been explored (Valencia-Flores et 
al.,2015)  .  
Some studies pointed precisely to the correlation between the hypoxemia degree and severity of 
peripheral neuropathy. All former studies noticed that peripheral neuropathy encompassing the sensory nerves in 
these patients (Kayacan et al.,2001 and  Ozge et al.,2001). 
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